We are live on ! Find out more
TC

Trilogy Capital Portfolio holdings

AUM $2.58B
1-Year Est. Return 22.97%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+22.97%
3 Year Est. Return
+54.11%
5 Year Est. Return
+45.31%
10 Year Est. Return
AUM
$1.74B
AUM Growth
+$122M
Cap. Flow
+$27.4M
Cap. Flow %
1.58%
Top 10 Hldgs %
31.03%
Holding
341
New
70
Increased
103
Reduced
110
Closed
52
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IUSG icon
151
iShares Core S&P US Growth ETF
IUSG
$31.1B
$1.06M 0.06%
9,048
-193
-2% -$21.5K
GOOGL icon
152
Alphabet (Google) Class A
GOOGL
$3.99T
$1.02M 0.06%
6,774
+2,339
+53% +$335K
SPHY icon
153
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.5B
$983K 0.06%
41,920
-3,313
-7% -$77.3K
NVDA icon
154
NVIDIA
NVDA
$4.76T
$979K 0.06%
10,840
+5,050
+87% +$366K
MOAT icon
155
VanEck Morningstar Wide Moat ETF
MOAT
$11.7B
$940K 0.05%
10,460
-3,125
-23% -$268K
MBB icon
156
iShares MBS ETF
MBB
$39.1B
$926K 0.05%
10,019
-2,037
-17% -$188K
SGOV icon
157
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.3B
$877K 0.05%
8,709
+5,486
+170% +$551K
AMZN icon
158
Amazon
AMZN
$2.49T
$876K 0.05%
4,856
+83
+2% +$13.9K
ABBV icon
159
AbbVie
ABBV
$454B
$868K 0.05%
4,767
-14,901
-76% -$2.57M
META icon
160
Meta Platforms (Facebook)
META
$1.51T
$852K 0.05%
1,754
+783
+81% +$349K
SUSC icon
161
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
$836K 0.05%
36,385
-234
-0.6% -$5.37K
ARKK icon
162
ARK Innovation ETF
ARKK
$5.74B
$830K 0.05%
16,579
-4,118
-20% -$201K
AOR icon
163
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.64B
$829K 0.05%
14,896
-2,883
-16% -$155K
MRK icon
164
Merck
MRK
$323B
$779K 0.04%
5,902
+3,112
+112% +$384K
FSIG icon
165
First Trust Limited Duration Investment Grade Corporate ETF
FSIG
$1.51B
$757K 0.04%
40,348
+142
+0.4% +$2.68K
TSLA icon
166
Tesla
TSLA
$1.22T
$755K 0.04%
4,294
+2,451
+133% +$479K
XLG icon
167
Invesco S&P 500 Top 50 ETF
XLG
$10.4B
$745K 0.04%
17,674
-1,300
-7% -$52.3K
VTV icon
168
Vanguard Value ETF
VTV
$189B
$744K 0.04%
4,571
-687
-13% -$106K
ALTL icon
169
Pacer Lunt Large Cap Alternator ETF
ALTL
$92.9M
$721K 0.04%
20,580
-4,482
-18% -$152K
JNJ icon
170
Johnson & Johnson
JNJ
$641B
$695K 0.04%
4,392
+2,099
+92% +$334K
JD icon
171
JD.com
JD
$41.8B
$691K 0.04%
+25,215
New +$617K
V icon
172
Visa
V
$689B
$660K 0.04%
2,364
+1,083
+85% +$299K
ESGE icon
173
iShares ESG Aware MSCI EM ETF
ESGE
$6.53B
$652K 0.04%
20,237
+1,843
+10% +$58.1K
VCIT icon
174
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
$649K 0.04%
+8,064
New +$647K
JPEM icon
175
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$384M
$633K 0.04%
11,842
-6,077
-34% -$321K

Similar funds

Trilogy Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Trilogy Capital held 341 positions worth $1.74B, up 7.5% from $1.62B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trilogy Capital's Q1 2024 filing shows 70 new, 103 increased, 110 reduced and 52 closed positions. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 1,202,118 shares worth $34.3M. The largest sale was WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund, an estimated $61.3M.

By sector, the portfolio is most concentrated in Technology at 1.5% of assets, up from 0.81% a quarter earlier, followed by Financials and Healthcare.

  • Trilogy Capital's largest Q1 2024 buy was Schwab Fundamental US Small Company Index ETF: 1,202,118 shares worth $34.3M.
  • Trilogy Capital added most to Vanguard Total Bond Market in Q1 2024, an estimated $55.7M increase.
  • Trilogy Capital's biggest Q1 2024 reduction was WisdomTree Yield Enhanced US Short-Term Aggregate Bond Fund, cutting an estimated $61.3M.
  • Trilogy Capital fully exited Invesco S&P SmallCap Low Volatility ETF in Q1 2024, selling an estimated $25.8M.
  • Trilogy Capital's ten largest holdings make up 31% of its $1.74B portfolio in Q1 2024.
  • Trilogy Capital opened 70 new positions and closed 52 in Q1 2024.
  • Trilogy Capital's portfolio value rose 7.5% quarter-over-quarter to $1.74B.

Based on Trilogy Capital's 13F filing for Q1 2024, filed 17 Apr 2024.